Metabolic fingerprint of insulin resistance in human polymorphonuclear leucocytes

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Palomino-Schatzlein, M
  • Simo, R
  • Hernandez, C
  • Ciudin, A
  • Mateos-Gregorio, P
  • Hernandez-Mijares, A
  • Herance, JR

Grupos

Abstract

The present study was aimed at determining the metabolic profile of PMNs in obese subjects, and to explore its potential relationship with insulin resistance (IR). To achieve this goal, a pilot clinical study was performed using PMNs from 17 patients with obesity and IR, and 17 lean controls without IR, which was validated in an additional smaller cohort (consisting of 10 patients and 10 controls). PMNs were isolated from peripheral blood and nuclear magnetic resonance was used to perform the metabolomic analysis. A total of 48 metabolites were quantified. The main metabolic change found in PMNs was a significant increase in 2-aminoisobutyric acid with a direct correlation with HOMA-IR (p<0.001), BMI (p<0.000001) and waist circumference (p<0.000001). By contrast, a decrease of 3-hydroxyisovalerate was observed with an inverse correlation with HOMA-IR (p = 0.001), BMI (p = 0.001) and waist circumference (p = 0.0001). Notably, the metabolic profile in plasma was different than that obtained in PMNs. In summary, our results suggest that the change in 3-hydroxyisovalerate and 2-aminoisobutyric is the key metabolic fingerprint in PMNs of obese subjects with IR. In addition, our methodology could be an easy and reliable tool for monitoring the effect of treatments in the setting of precision medicine.

Datos de la publicación

ISSN/ISSNe:
1932-6203, 1932-6203

Plos One  PUBLIC LIBRARY SCIENCE

Tipo:
Article
Páginas:
-
PubMed:
30005063
Factor de Impacto:
1,100 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 8

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • CHAIN AMINO-ACIDS; ADIPONECTIN; OBESITY; PLASMA

Campos de Estudio

Proyectos y Estudios Clínicos

UNA APROXIMACIÓN ÓMICA AL DIAGNÓSTICO DE LA TUBERCULOSIS

PCIN-2013-041 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2015

HERRAMIENTAS DE RMN PARA EL DESARROLLO DE UNA PLATAFORMA PARA LA IDENTIFICACIÓN DE DIANAS, LA EVALUACIÓN DE FÁRMACOS Y LA PERSONALIZACIÓN DE TRATAMIENTOS BASADA EN APROXIMACIONES METABOLÓMICAS

Investigador Principal: ANTONIO PINEDA LUCENA

SAF2014-53977-R . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2015

RECALL. DESARROLLO DE PROTOTIPOS QUÍMICOS ORIENTADOS A LA GENERACIÓN DE TERAPIAS AVANZADAS PARA EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER

Investigador Principal: ANTONIO PINEDA LUCENA

RTC-2016-4803-1 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2016

Plataforma de Innovación en Tecnologías Médicas y Sanitarias - ITEMAS

Investigador Principal: SILVIA SÁNCHEZ SALVO

PT17/0005/0011 . INSTITUTO DE SALUD CARLOS III . 2018

Identificación de biotipos moleculares de cáncer de próstata como base de una medicina de precisón (BIOChiP).

Investigador Principal: LÓPEZ

PROMETEO/2016/103 . 2016

Cita

Compartir